Package 65757-401-03

Brand: aristada

Generic: aripiprazole lauroxil
NDC Package

Package Facts

Identity

Package NDC 65757-401-03
Digits Only 6575740103
Product NDC 65757-401
Product ID 65757-401_3d951a36-1e73-4f84-8ebf-4d556d81a086
Description

1 SYRINGE in 1 CARTON (65757-401-03) / 1.6 mL in 1 SYRINGE

Marketing

Marketing Status
Marketed Since 2015-10-05
Brand aristada
Generic aripiprazole lauroxil
Sample Package No

Linked Drug Pages (1)

ARISTADA ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "3d951a36-1e73-4f84-8ebf-4d556d81a086", "openfda": {"unii": ["B786J7A343"], "rxcui": ["1673269", "1673274", "1673277", "1673278", "1673279", "1673280", "1925262", "1925264"], "spl_set_id": ["17a8d11b-73b0-4833-a0b4-cf1ef85edefb"], "manufacturer_name": ["Alkermes, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (65757-401-03)  / 1.6 mL in 1 SYRINGE", "package_ndc": "65757-401-03", "marketing_start_date": "20151005"}, {"sample": true, "description": "1 SYRINGE in 1 CARTON (65757-401-04)  / 1.6 mL in 1 SYRINGE", "package_ndc": "65757-401-04", "marketing_start_date": "20151005"}], "brand_name": "ARISTADA", "product_id": "65757-401_3d951a36-1e73-4f84-8ebf-4d556d81a086", "dosage_form": "INJECTION, SUSPENSION, EXTENDED RELEASE", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "65757-401", "generic_name": "aripiprazole lauroxil", "labeler_name": "Alkermes, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ARISTADA", "active_ingredients": [{"name": "ARIPIPRAZOLE LAUROXIL", "strength": "441 mg/1.6mL"}], "application_number": "NDA207533", "marketing_category": "NDA", "marketing_start_date": "20151005", "listing_expiration_date": "20261231"}